A detailed history of Christopher J. Hasenberg, Inc transactions in Nutri Band Inc. stock. As of the latest transaction made, Christopher J. Hasenberg, Inc holds 200 shares of NTRB stock, worth $1,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Holding current value
$1,296
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 30, 2025

BUY
$4.07 - $9.39 $814 - $1,878
200 New
200 $1,000

Others Institutions Holding NTRB

About NutriBand Inc.


  • Ticker NTRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,803,260
  • Market Cap $50.6M
  • Description
  • Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...
More about NTRB
Track This Portfolio

Track Christopher J. Hasenberg, Inc Portfolio

Follow Christopher J. Hasenberg, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Christopher J. Hasenberg, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Christopher J. Hasenberg, Inc with notifications on news.